Amarin Corp Plc (AMRN)

[Mogwai]

But in your scenario, AMRN is getting nothing. If REDUCE-IT stopped early, your theory is that AMRN promotes REDUCE-IT and the FDA then approves REDUCE-IT in the meantime. This is nothing extra. AMRN has the PI, and they could have went for the final judgment by now, so they could already promote REDUCE-IT via the PI or final judgement. So nothing extra there. And if REDUCE-IT is stopped early, results would have to be great, so the FDA would presumably approve REDUCE-IT regardless of whether they settle or not. So nothing extra there. So what exactly is AMRN getting extra that they wouldn't have gotten if they didn't drop the 1A case?